lung cancer

Oncology

Innovation, real-world data, and precision medicine: Pierre ...

Ahead of ASCO 2025, Pierre Fabre charts bold progress in NSCLC with targeted therapies, real-world data, and innovative partnerships

News

CRUK scientists find new tool to test lung cancer therapies

Researchers in the UK have developed a lung cancer cell line that they believe could be an important new tool for the discovery of new therapies.

Oncology

12 Questions with Mimi Huizinga

Dr Mimi Huizinga is Vice President, Oncology Medical Affairs, Lung Cancer at AstraZeneca.

Oncology

Inside ESMO 2024: Treatments, trials, and top HCPs on social...

Discover the latest treatments, clinical trials, and top healthcare professionals sharing insights on social media from the ESMO 2024 conference.

Oncology

Beyond COVID-19: mRNA vaccines aim to revolutionise cancer c...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment.

News

J&J nets another key approval for blockbuster hope Rybrevant

Johnson & Johnson's target of $5 billion in sales for its EGFRxMET bispecific antibody Rybrevant has moved a step closer, after a new FDA approval in non-small cell lung cancer (NSCLC).

Innovation, real-world data, and precision medicine: Pierre ...

CRUK scientists find new tool to test lung cancer therapies

12 Questions with Mimi Huizinga

Inside ESMO 2024: Treatments, trials, and top HCPs on social...

Beyond COVID-19: mRNA vaccines aim to revolutionise cancer c...

J&J nets another key approval for blockbuster hope Rybrevant

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

lung cancer

Editor's Picks